Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1868 of 5804
-
Can radio waves zap dry eye away? new trial tests device for stubborn cases
Symptom relief Recruiting nowThe goal of this prospective, 24-week, double-masked, randomized, sham-controlled clinical trials to compare clinical efficacy and safety of RF and MGX with MGX alone in patients with meibomian gland dysfunction-related dry eye disease. The main question it aims to answer is whet…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Blood filter shows promise for severe psoriasis in early trial
Disease control CompletedPsoriasis is a chronic, inflammatory skin condition driven by the immune system, marked by red, scaly plaques that commonly affect the scalp and nails. About 30% of psoriasis patients may develop psoriatic arthritis, especially those with severe psoriasis or lesions on the nails …
Phase: NA • Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for short kids: experimental drug takes on growth hormone
Disease control Recruiting nowThe purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH)(hGH; only in the United States), in children with idiopathic short stature (ISS).
Phase: PHASE2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Flu vaccine may tame heart inflammation, small study hints
Disease control CompletedObservational and randomized studies suggest that influenza vaccine may reduce future cardiovascular events in patients with cardiovascular disease. Beyond classical view of indirect effect, linked to the neutralisation of the virus, it is currently considered whether the vaccina…
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Weekly HIV pill shows promise but study halted early
Disease control TerminatedThe goal of this clinical study is to learn more about the experimental drugs lepetegravir (formerly GS-1720) (an oral, long-acting integrase strand transfer inhibitor (INSTI)) and lenacapavir pacfosacil (formerly GS-4182) (a prodrug of Lenacapavir (LEN)); to compare the combinat…
Phase: PHASE2, PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
When to thin blood after brain bleed? new trial seeks answer
Disease control Recruiting nowThe objective of this randomized clinical trial is to evaluate the safety and efficiency of different anticoagulation schemes with heparin for venous thromboembolism prevention in patients with hypertensive intracerebral hemorrhage. The main questions it aims to answer are: * Wh…
Phase: NA • Sponsor: Pirogov Russian National Research Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
App aims to prevent disease and boost mental Well-Being in thousands
Prevention CompletedNon-communicable diseases (NCDs), such as cardiovascular disease, diabetes, or cancer, and common mental disorders (CMDs), such as depression or anxiety, represent the primary causes of death and disability worldwide, causing major health and financial burdens. Lifestyle behaviou…
Phase: NA • Sponsor: Singapore ETH Centre • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Could a diabetes pill help lungs? new trial explores empagliflozin for PAH
Disease control Recruiting nowThe goal of this clinical trial is to learn if empagliflozin works to treat patients with pulmonary arterial hypertension. It will also learn about the safety of empagliflozin. The main questions it aims to answer are: Based on standard treatment, does empagliflozin reduce pulmo…
Phase: PHASE1 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Virtual ward aims to keep heart failure patients home
Disease control Recruiting nowThe main aim will be to evaluate whether a follow-up with virtual wards reduces HF hospitalisation at three months follow-up. Hospital admission will be defined as any hospital admission, or an emergency room stay of more than 24 h requiring IV diuretics. The secondary objective…
Phase: NA • Sponsor: National University of Ireland, Galway, Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Brain tissue bank could unlock secrets of recovery after head trauma
Knowledge-focused Recruiting nowThe TRAUMAP study will function as a brain tissue repository for biopsy specimens from patients with traumatic brain injury undergoing brain surgery for contusion removal.
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Smartphone ECG with AI could spot hidden heart disease in families
Diagnosis CompletedThe purpose of this study is to assess the feasibility and impact of screening FDR of DCM probands using a mobile ECG with the ability to transmit the ECG for cloud-based AI analysis to detect reduced left ventricular ejection fraction (LVEF). This protocol will examine the impac…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Simple home workouts may ease slowness in Parkinson's
Symptom relief CompletedExercises that involve increasing the speed of movements are beneficial for individuals with Parkinson's disease (PD) and have the potential to reduce bradykinesia and improve mobility. High-speed bodyweight resistance training is a treatment that involves increasing speed consid…
Phase: NA • Sponsor: Federal University of Minas Gerais • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to help HIV patients kick the habit for good
Disease control Recruiting nowThis study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living wi…
Phase: PHASE4 • Sponsor: New York University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New depression pill faces off against leading drug in major trial
Symptom relief CompletedThe purpose of this study is using Duloxetine Hydrochloride Enteric Capsules as the positive control, to evaluate the efficacy and safety of Levomilnacipran Hydrochloride Extended-Release Capsules in patients with Major Depressive Disorder (MDD).
Phase: PHASE3 • Sponsor: Zhejiang Huahai Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Glucose monitor may spot diabetes risk after pancreatitis
Knowledge-focused Recruiting nowThe DREAM-ON study will investigate whether continuous glucose monitoring (CGM) is useful to predict risk for developing diabetes mellitus (DM) and pre-diabetes mellitus (PDM), the need for insulin therapy among those who develop DM, and to determine whether CGM can provide insig…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New practice method aims to help stroke survivors find lost words
Disease control CompletedAphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today. A common problem in aphasia involves difficulty retrieving known words in the course of language product…
Phase: NA • Sponsor: Albert Einstein Healthcare Network • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New pill could lift bipolar depression
Symptom relief CompletedBipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. This study will assess how safe and effective ABBV-932 is in treating participants with bipolar I or II disorder. ABBV-932 is an investigational drug being deve…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Antioxidant shows promise in sepsis battle
Disease control CompletedEvaluate the of effect of alpha-lipoic acid in critically ill septic patients. 80 septic patients will be enrolled from Damanhur National medical institute, and they will be randomized using simple randomization into control group will receive placebo and ALA group will be given …
Phase: NA • Sponsor: Damanhour University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a camera replace the slit lamp for Post-Surgery eye checks?
Diagnosis CompletedThe prospective, (observer) blinded clinical trial at the University Hospital for Ophthalmology includes patients routinely scheduled for cataract surgery at the Medical University of Innsbruck. Patients are enrolled one week prior to their planned cataract surgery. The particip…
Phase: NA • Sponsor: Medical University Innsbruck • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New drug elafibranor tested in everyday use for rare liver disease
Disease control Recruiting nowThis study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged. The liver damage in PBC may le…
Sponsor: Ipsen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC